Adis Journal Podcasts

In this podcast, Thanyanan Reungwetwattana from the Division of Medical Oncology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, Kristin A. Higgins from the Department of Radiation Oncology, City of Hope Cancer Center Atlanta, Atlanta, GA, USA, Ignacio Casarini from the Servicio Oncología, Hospital Bernardo Houssay, Mar del Plata, Buenos Aires, Argentina, and Suresh S. Ramalingam from the Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA discuss considerations surrounding the implementation of the LAURA (NCT03521154) regimen (osimertinib after chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer) in clinical...

In this podcast, Shailender Bhatia from the Division of Hematology and Oncology, Department of Medicine, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA, Sandra D’Angelo from the Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA, and Paul Nghiem from the Department of Dermatology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA summarize key studies of ICIs in advanced MCC, including clinical trials and real-world studies, and discuss clinical evidence related to practical considerations, such as elective discontinuation of ICI treatment, and treatment...

In this podcast, Wade T. Iams from the Greco-Hainsworth Centers for Research Tennessee Oncology, Nashville, TN, USA and Narjust Florez form the Dana-Farber Cancer Institute and the Harvard Medical School, Boston, MA, USA discuss safety considerations with MET TKI treatment for patients with METex14 skipping NSCLC.
This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published podcast article through the Targeted Oncology website and by using this link: https://link.springer.com/article/10.1007/s11523-026-01242-z. All conflicts of interest can be found online.
Open Access: This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License,...

In this podcast, Maryam B. Lustberg from the Smilow Cancer Hospital at Yale, New Haven, CT, USA, Megan-Claire Chase, Life on the Cancer Train, Atlanta, GA, USA, Stacey Tinianov, Advocates for Collaborative Education, Santa Cruz, CA, USA, and Kevin Kalinsky from the Winship Cancer Institute at Emory University, Atlanta, GA, USA discuss the risk of recurrence for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer including early and late risk of recurrence, discuss how risk is assessed, and examine the evolving treatment landscape for reducing risk..
This podcast is published open access in Targeted Oncology and...